(CSE:HUGE-OTCQB:FSDDF) Executive Co-Chairman and CEO Dr Raza Bokhari sat down with Steve Darling from Proactive Investors Vancouver to talk about FSD hitting a company milestone by receiving their cannabis sales license from Health Canada.
Dr Bokhari also told Proactive about their recent acquisition of Prismic Pharmaceuticals. That company is a US-based speciality R&D pharmaceutical company that is developing novel non-addictive prescription drugs with unique safety profiles with the goal of addressing the opioid crisis based on formulations utilizing micro-palmitoylethanolamide’s “entourage” effect on certain drugs impacting the endocannabinoid system.
CSE:HUGE
Market: CSE
Market Cap: $63.39 m
Follow
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of FSD Pharma named herein, including the promotion by the Company of FSD Pharma in any Content on the Site, the Company receives from said issuer...
FOR OUR FULL DISCLAIMER CLICK HEREMost read
FSD Pharma rings the Nasdaq opening bell in 'exciting and momentous moment'
FSD Pharma Inc (NASDAQ:HUGE) (CSE:HUGE) CEO Raza Bokhari, who runs the pharmaceutical cannabis research company, rang the Nasdaq opening bell together with with members of the board, leadership team, early investors, and others. Bokhari says it was an 'exciting and momentous moment' for the...
1 week, 2 days ago
2 min read
Prev article
4 min read
